Stock comparison

JAZZvsJNJ

Jazz Pharmaceuticals PLCvsJohnson & Johnson. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

JAZZ

Jazz Pharmaceuticals PLC

$199.96

+17.95%

Pharmaceuticals$11.5BNASDAQ

JNJ

Johnson & Johnson

$230.65

+9.01%

Pharmaceuticals$585.7BNYSE

60-day price, rebased to 100

JAZZ +21.94% · JNJ +1.29%

Round-by-round

JAZZ 4·JNJ 2

EdgeJAZZ

Valuation upside

-5.90% vs -37.60% to DCF fair value

EdgeJNJ

Balance-sheet strength

Altman Z 1.73 vs 5.08

EdgeJAZZ

Fundamental quality

Piotroski 5.00 vs 4.00 (of 9)

EdgeJAZZ

Growth + margins

Rule-of-40 31.70 vs 26.60

EdgeJAZZ

60-day momentum

+21.94% vs +1.29% price return

EdgeJNJ

Market-cap liquidity

$11.5B vs $585.7B

Verdict

Across6categories,JAZZtakes the edge with4wins to2. Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onJAZZorJNJ

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.